Robert P. Davis’ practice focuses on a broad range of corporate and financial matters.
He advises boards of directors, senior representatives of private equity sponsors, management and finance teams, and their financial advisors in connection with the execution of major acquisition and divestiture projects, post-closing integration plans, and the management of investigations and third-party disputes. He also has experience representing strategic and private equity clients in public and private mergers, acquisitions, divestitures, joint ventures, acquisition financings, international securities offerings, corporate restructurings and reorganizations, and other financial transactions.
Bob joined the firm in 1978, became a partner in 1986, and became senior counsel in 2019. From 1993 through 1995, he was resident in the Hong Kong office.
OCI in its proposed $8 billion combination with CF Industries.
American Tower in its $5 billion acquisition and leasing of wireless towers from Verizon.
Biomet and its four private equity consortium owners—Blackstone, Goldman Sachs PIA, KKR, and TPG—in Biomet’s $13.35 billion cash and stock merger with Zimmer Holdings.
Neiman Marcus, TPG, and Warburg Pincus in the $6 billion sale of Neiman Marcus to Ares Management and CPPIB.
Warburg Pincus and Bausch + Lomb in the $8.7 billion sale of Bausch + Lomb to Valeant Pharmaceuticals.
Biomet in its acquisition of the global trauma business of DePuy Orthopaedics Inc.
Barclays Capital in the purchase of Lehman Brothers U.S. and Canadian investment banking and capital markets businesses, and its Manhattan headquarters and certain other real estate.
Warburg Pincus in its acquisition of numerous portfolio companies.
The Master Executive Council of the airline pilots of Delta Air Lines in connection with the merger of Delta with Northwest Airlines and ongoing matters.
Ongoing advice to, among others, Cascade Investment, American Tower, and T-Mobile US.